Related Experiment Video
Updated: Mar 2, 2026

Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling
Published on: April 19, 2024
Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes?
Dhanunjaya R Lakkireddy1, George E Blake1, Dimpi Patel2
1Mid America Cardiology @ University of Kansas Hospital, Kansas City, KS.
Insights
Obesity significantly increases the risk of atrial fibrillation (AF) recurrence after catheter ablation. Higher body mass index (BMI) correlates with greater AF relapse rates, impacting long-term treatment success.
Area of Science:
- Cardiology
- Electrophysiology
- Obesity Medicine
Background:
- Catheter ablation is a common treatment for symptomatic atrial fibrillation (AF) refractory to antiarrhythmic drugs.
- Higher body mass index (BMI) is linked to poorer outcomes in cardiovascular interventions, but its specific impact on AF ablation success is unclear.
Purpose of the Study:
- To investigate the association between body mass index (BMI) and the success rate of catheter ablation for atrial fibrillation (AF).
Main Methods:
- A prospective study of 511 patients undergoing AF ablation between 2002-2005.
- Patients were stratified into four BMI classes (I to IV).
- AF recurrence after 3 months, confirmed by follow-up for at least 12 months, defined ablation failure.
Main Results:
- Higher BMI classes (III and IV) showed increased prevalence of male sex, diabetes, smoking, coronary artery disease, left atrial enlargement, and longstanding AF.
- Obesity, measured by BMI, demonstrated a direct correlation with both early (p=0.05) and late (p=0.01) AF recurrence post-ablation.
Conclusions:
- Obesity is a significant predictor of long-term atrial fibrillation recurrence following catheter ablation.
- Factors such as smoking and left atrial enlargement may contribute to higher failure rates in obese patient subgroups.
Abstract:
Background: Catheter ablation of atrial fibrillation (AF) is an increasingly popular therapeutic option for symptomatic patients who have failed multiple antiarrhythmic drugs (AADs). Patients of higher body mass index often fail direct current cardioversion. The role of body mass index (BMI) on the success of AF ablation is not well understood. Methods: We prospectively studied 511 patients who underwent AF ablation at the Cleveland Clinic Foundation between 2002 and 2005. Patients were divided into four classes based on their BMI: Class I ( 25); Class II (25.1-30); Class III (30.1-35) and Class IV (>35). These groups were compared for baseline demographic and clinical characteristics. Any recurrence of AF after 3 months of ablation was considered as failure. All classes were followed for at least 12 months and rates of failure were compared. Results: Based on their BMI, 25% of patients were assigned to class I, 37% in class II, 21% in class III and 16% in class IV. Patients of higher classification (class III or IV) were more likely to be male (p<0.001), diabetic (p<0.001), smokers (p=0.002), with coronary artery disease (=0.018), left atrial enlargement (p=0.015) and longstanding AF (p=0.007). Severity of obesity as measured by BMI had a direct correlation to early (p=0.05) and late (p=0.01) recurrence of AF. Conclusion: Obesity is significantly associated with long-term AF recurrence after catheter ablation. Higher incidence of smoking & left atrial enlargement may possibly contribute to higher failure rates in this sub-group of patients.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Drug Dosing: Obese Patients

